Rothschild Investment LLC Standard Biotools Inc. Call Options Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding LAB
# of Institutions
150Shares Held
263MCall Options Held
422KPut Options Held
40.7K-
Casdin Capital, LLC New York, NY64MShares$130 Million9.76% of portfolio
-
Viking Global Investors LP58.7MShares$120 Million0.41% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$44.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$32.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY12.9MShares$26.4 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $160M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...